Net clinical benefit
Considering all the above-mentioned components of the primary outcomes, the combined hazard outcome, i.e., the net clinical benefit was similar for both strategies (13.6% vs. 11.8%; HR, 1.23; 95%CI, 0.75-2.02; P=0.39; Table 3).